Medical Nutrition Market Research Report - Forecast till 2027

タイプ(小児栄養、非経口栄養、高齢者栄養およびスポーツ栄養)、製品タイプ(アミノ酸溶液、複数のビタミンおよび抗酸化物質、脂質エマルジョン、微量元素およびチャンバーバッグ)、投与経路(非経口および経口)、用途別(小児栄養失調、消化器疾患、腎不全、がん、肺疾患、糖尿病、神経疾患)、流通チャネル別(病院、調剤薬局、小売薬局、電子商取引ウェブサイト)-2027年までの予測

ID: MRFR/Pharma/0822-CR | February 2021 | Region: Global | 168 Pages         

1 Report Prologue

1.1 Scope of Study 18

1.2 Research Objective 18

1.3 List of Assumptions 18

1.4 Market Structure 19

2 Research Methodology

2.1 Research Process 21

2.2 Primary Research 22

2.3 Secondary Research 23

2.4 Market Size Estimation 24

2.5 Forecast Model 24

3 Market Dynamics

3.1 Introduction 26

3.2 Drivers 26

3.2.1 Escalating Occurrences of Lifestyle-Associated Diseases 26

3.2.2 High Birth Rate and High Number of Premature Birth 27

3.2.3 The Upsurge in the Number of Victims of Malnutrition Receiving Treatments 28

3.2.4 Growing Geriatric Population is Influencing the Medical Nutrition Uptake 29

3.3 Restraints 30

3.3.1 Stringent Regulations and Reimbursement Issues 30

3.3.2 Lack of Awareness Limits the Clinical Nutrition Market 30

3.4 Opportunities 31

3.4.1 Increasing Demand for Clinical Nutrition in Infant Category 31

3.4.2 Increasing Home Care Usage of Nutritional Products 31

3.5 Challenges 32

3.5.1 Negative Publicity and Presence of Misbranded 32

3.5.2 Macroeconomic Indicators 32

4 Medical Nutrition Market, By Type

4.1 Introduction 34

4.1.1 Pediatric Nutrition 35

4.1.2 Parenteral Nutrition 36

4.1.3 Elderly Nutrition 37

4.1.4 Sport Nutrition 38

5 Medical Nutrition Market, By Product Type

5.1 Introduction 40

5.1.1 Amino Acid Solution 41

5.1.2 Multiple Vitamins and Antioxidants 42

5.1.3 Lipid Emulsion 42

5.1.4 Trace Elements 43

5.1.5 Chamber Bags 43

6 Medical Nutrition Market, By Route of Administration

6.1 Introduction 46

6.1.1 Parenteral 47

6.1.2 Oral 47

7 Medical Nutrition Market, By Application

7.1 Introduction 49

7.1.1 Pediatric malnutrition 51

7.1.2 Gastrointestinal Diseases 51

7.1.3 Renal Failure 52

7.1.4 Cancer 52

7.1.5 Pulmonary Diseases 53

7.1.6 Diabetes 53

7.1.7 Neurological Diseases 54

8 Medical Nutrition Market, By Distribution Channel

8.1 Introduction 56

8.1.1 Hospitals 57

8.1.2 Compounding Pharmacy 57

8.1.3 Retail Pharmacy 58

8.1.4 E-Commerce Websites 58

9 Global Medical Nutrition Market, By Region

9.1 Introduction 60

9.2 Americas 61

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.2.1 North America 65

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.2.1.1 US 68

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.2.1.2 Canada 71

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.2.2 South America 73

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3 Europe 77

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.1 Germany 81

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.2 UK 84

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.3 France 87

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.4 Spain 90

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.5 Italy 93

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.3.6 Rest of Europe 96

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4 Asia-Pacific 99

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4.1 China 103

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4.2 Japan 106

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4.3 India 109

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4.4 Australia 112

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.4.5 Rest of Asia-Pacific 115

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.5 Middle East & Africa 118

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.5.1 Middle East 122

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

9.5.2 Africa 125

Medical Nutrition Market, By Type

Medical Nutrition Market, By Product Type

Medical Nutrition Market, By Route of Administration

Medical Nutrition Market, By Application

Medical Nutrition Market, By Distribution Channel

10 Competitive Landscape

10.1 Competitive Scenario 129

10.1.1 Introduction 129

10.2 Company Market Share Analysis 130

10.2.1 Introduction 130

10.3 Key Developments 132

11 Company Profile

11.1 Nestle Health Science 134

11.1.1 Company Overview 134

11.1.2 Financial Overview 134

11.1.3 Products Offering 135

11.1.4 Key Developments 135

11.1.5 SWOT Analysis 136

11.1.6 Key Strategy 136

11.2 Baxter Healthcare Corporation 137

11.2.1 Company Overview 137

11.2.2 Financial Overview 137

11.2.3 Products Offering 138

11.2.4 Key Developments 138

11.2.5 SWOT Analysis 138

11.2.6 Key Strategy 138

11.3 Sanofi 139

11.3.1 Company Overview 139

11.3.2 Financial Overview 139

11.3.3 Products Offering 140

11.3.4 Key Developments 140

11.3.5 SWOT Analysis 140

11.3.6 Key Strategy 141

11.4 Pfizer Inc. 142

11.4.1 Company Overview 142

11.4.2 Financial Overview 142

11.4.3 Products Offering 143

11.4.4 Key Developments 143

11.4.5 SWOT Analysis 143

11.4.6 Key Strategy 143

11.5 Abbott Nutrition 144

11.5.1 Company Overview 144

11.5.2 Financial Overview 144

11.5.3 Products Offering 145

11.5.4 Key Developments 145

11.5.5 SWOT Analysis 146

11.5.6 Key Strategy 146

11.6 GlaxoSmithKline PLC (GSK) 147

11.6.1 Company Overview 147

11.6.2 Financial Overview 147

11.6.3 Products Offering 148

11.6.4 Key Developments 148

11.6.5 SWOT Analysis 148

11.6.6 Key Strategy 148

11.7 Mead Johnson Nutrition Company 149

11.7.1 Company Overview 149

11.7.2 Financial Overview 149

11.7.3 Products Offering 150

11.7.4 Key Developments 150

11.7.5 SWOT Analysis 150

11.7.6 Key Strategy 151

11.8 Bayer AG 152

11.8.1 Company Overview 152

11.8.2 Financial Overview 152

11.8.3 Products Offering 153

11.8.4 Key Developments 153

11.8.5 SWOT Analysis 153

11.8.6 Key Strategy 153

11.9 Danone Nutricia 154

11.9.1 Company Overview 154

11.9.2 Financial Overview 154

11.9.3 Products Offering 155

11.9.4 Key Developments 155

11.9.5 SWOT Analysis 156

11.9.6 Key Strategy 156

11.10 Danisco (DuPont) 157

11.10.1 Company Overview 157

11.10.2 Products Offering 158

11.10.3 Key Developments 158

11.10.4 SWOT Analysis 158

11.10.5 Key Strategy 158

11.11 Grifols SA 159

11.11.1 Company Overview 159

11.11.2 Financial Overview 159

11.11.3 Products Offering 160

11.11.4 Key Developments 160

11.11.5 SWOT Analysis 160

11.11.6 Key Strategy 160

11.12 B. Braun Melsungen AG 161

11.12.1 Company Overview 161

11.12.2 Financial Overview 161

11.12.3 Products Offering 162

11.12.4 Key Developments 162

11.12.5 SWOT Analysis 163

11.12.6 Key Strategy 163

11.13 Fresenius Kabi AG 164

11.13.1 Company Overview 164

11.13.2 Financial Overview 164

11.13.3 Products Offering 165

11.13.4 Key Developments 165

11.13.5 SWOT Analysis 165

11.13.6 Key Strategy 165

12 Appendix

12.1 Discussion Blue Print 167

13 List of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 COUNTRY-WISE PREVALENCE OF UNDERNOURISHMENT, 2020–2020 (%) 28

TABLE 3 GLOBAL MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 34

TABLE 4 GLOBAL MEDICAL NUTRITION MARKET FOR PEDIATRIC NUTRITION, BY REGION 2020–2027 (USD MILLION) 35

TABLE 5 GLOBAL MEDICAL NUTRITION MARKET FOR PARENTERAL NUTRITION, BY REGION 2020–2027 (USD MILLION) 36

TABLE 6 GLOBAL MEDICAL NUTRITION MARKET FOR ELDERLY NUTRITION, BY REGION 2020–2027 (USD MILLION) 37

TABLE 7 GLOBAL MEDICAL NUTRITION MARKET FOR SPORT NUTRITION, BY REGION 2020–2027 (USD MILLION) 38

TABLE 8 GLOBAL MEDICAL NUTRITION MARKET FOR AMINO ACID SOLUTION, BY PRODUCT TYPE 2020–2027 (USD MILLION) 40

TABLE 9 GLOBAL MEDICAL NUTRITION MARKET FOR AMINO ACID SOLUTION, BY REGION 2020–2027 (USD MILLION) 41

TABLE 10 GLOBAL MEDICAL NUTRITION MARKET FOR MULTIPLE VITAMINS AND ANTIOXIDANTS, BY REGION 2020–2027 (USD MILLION) 42

TABLE 11 GLOBAL MEDICAL NUTRITION MARKET FOR LIPID EMULSION, BY REGION 2020–2027 (USD MILLION) 42

TABLE 12 GLOBAL MEDICAL NUTRITION MARKET FOR TRACE ELEMENTS, BY REGION 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL MEDICAL NUTRITION MARKET FOR CHAMBER BAGS, BY REGION 2020–2027 (USD MILLION) 43

TABLE 14 PARENTERAL PRODUCTS: COMPANY-WISE (NUTRITIONAL CONTENT) 44

TABLE 15 GLOBAL MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 46

TABLE 16 GLOBAL MEDICAL NUTRITION MARKET FOR PARENTERAL, BY REGION 2020–2027 (USD MILLION) 47

TABLE 17 GLOBAL MEDICAL NUTRITION MARKET FOR ORAL, BY REGION 2020–2027 (USD MILLION) 47

TABLE 18 GLOBAL MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 49

TABLE 19 GLOBAL MEDICAL NUTRITION MARKET, FOR GASTROINTESTINAL DISEASES BY TYPE, 2020–2027 (USD MILLION) 50

TABLE 20 GLOBAL MEDICAL NUTRITION MARKET, FOR CANCER BY TYPE 2020–2027 (USD MILLION) 50

TABLE 21 GLOBAL MEDICAL NUTRITION MARKET, FOR PULMONARY DISEASES BY TYPE 2020–2027 (USD MILLION) 50

TABLE 22 GLOBAL MEDICAL NUTRITION MARKET FOR PEDIATRIC MALNUTRITION, BY REGION 2020–2027 (USD MILLION) 51

TABLE 23 GLOBAL MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY REGION 2020–2027 (USD MILLION) 51

TABLE 24 GLOBAL MEDICAL NUTRITION MARKET FOR RENAL FAILURE, BY REGION 2020–2027 (USD MILLION) 52

TABLE 25 GLOBAL MEDICAL NUTRITION MARKET FOR CANCER, BY REGION 2020–2027 (USD MILLION) 52

TABLE 26 GLOBAL MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY REGION 2020–2027 (USD MILLION) 53

TABLE 27 GLOBAL MEDICAL NUTRITION MARKET FOR DIABETES, BY REGION 2020–2027 (USD MILLION) 53

TABLE 28 GLOBAL MEDICAL NUTRITION MARKET FOR NEUROLOGICAL DISEASES, BY REGION 2020–2027 (USD MILLION) 54

TABLE 29 GLOBAL MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 56

TABLE 30 GLOBAL MEDICAL NUTRITION MARKET FOR HOSPITALS, BY REGION 2020–2027 (USD MILLION) 57

TABLE 31 GLOBAL MEDICAL NUTRITION MARKET FOR COMPOUNDING PHARMACY, BY REGION 2020–2027 (USD MILLION) 57

TABLE 32 GLOBAL MEDICAL NUTRITION MARKET FOR RETAIL PHARMACY, BY REGION 2020–2027 (USD MILLION) 58

TABLE 33 GLOBAL MEDICAL NUTRITION MARKET FOR E-COMMERCE WEBSITES, BY REGION 2020–2027 (USD MILLION) 58

TABLE 34 GLOBAL MEDICAL NUTRITION MARKET, BY REGION 2020–2027 (USD MILLION) 60

TABLE 35 AMERICAS MEDICAL NUTRITION MARKET, BY REGION 2020–2027 (USD MILLION) 61

TABLE 36 AMERICAS MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 62

TABLE 37 AMERICAS MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 62

TABLE 38 AMERICAS MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 62

TABLE 39 AMERICAS MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 63

TABLE 40 AMERICAS MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 63

TABLE 41 AMERICAS MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 63

TABLE 42 AMERICAS MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 64

TABLE 43 AMERICAS MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 64

TABLE 44 NORTH AMERICA MEDICAL NUTRITION MARKET, BY COUNTRY 2020–2027 (USD MILLION) 65

TABLE 45 NORTH AMERICA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 65

TABLE 46 NORTH AMERICA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 66

TABLE 47 NORTH AMERICA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 66

TABLE 48 NORTH AMERICA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 66

TABLE 49 NORTH AMERICA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 50 NORTH AMERICA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 51 NORTH AMERICA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 52 NORTH AMERICA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 68

TABLE 53 US MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 68

TABLE 54 US MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 68

TABLE 55 US MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 69

TABLE 56 US MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 69

TABLE 57 US MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 69

TABLE 58 US MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 70

TABLE 59 US MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 70

TABLE 60 US MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 70

TABLE 61 CANADA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 71

TABLE 62 CANADA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 71

TABLE 63 CANADA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 71

TABLE 64 CANADA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72

TABLE 65 CANADA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 72

TABLE 66 CANADA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 72

TABLE 67 CANADA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 73

TABLE 68 CANADA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73

TABLE 69 SOUTH AMERICA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 73

TABLE 70 SOUTH AMERICA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 74

TABLE 71 SOUTH AMERICA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 74

TABLE 72 SOUTH AMERICA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 74

TABLE 73 SOUTH AMERICA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 75

TABLE 74 SOUTH AMERICA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 75

TABLE 75 SOUTH AMERICA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 75

TABLE 76 SOUTH AMERICA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76

TABLE 77 EUROPE MEDICAL NUTRITION MARKET, BY COUNTRY 2020–2027 (USD MILLION) 77

TABLE 78 EUROPE MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 78

TABLE 79 EUROPE MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 78

TABLE 80 EUROPE MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 79

TABLE 81 EUROPE MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 79

TABLE 82 EUROPE MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 79

TABLE 83 EUROPE MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 80

TABLE 84 EUROPE MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 80

TABLE 85 EUROPE MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 80

TABLE 86 GERMANY MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 81

TABLE 87 GERMANY MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 81

TABLE 88 GERMANY MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 81

TABLE 89 GERMANY MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 82

TABLE 90 GERMANY MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 82

TABLE 91 GERMANY MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 82

TABLE 92 GERMANY MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 83

TABLE 93 GERMANY MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 83

TABLE 94 UK MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 84

TABLE 95 UK MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 84

TABLE 96 UK MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 84

TABLE 97 UK MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 85

TABLE 98 UK MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 85

TABLE 99 UK MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 85

TABLE 100 UK MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 86

TABLE 101 UK MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 86

TABLE 102 FRANCE MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 87

TABLE 103 FRANCE MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 87

TABLE 104 FRANCE MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 87

TABLE 105 FRANCE MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 88

TABLE 106 FRANCE MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 88

TABLE 107 FRANCE MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 88

TABLE 108 FRANCE MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 89

TABLE 109 FRANCE MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 89

TABLE 110 SPAIN MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 90

TABLE 111 SPAIN MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 90

TABLE 112 SPAIN MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 90

TABLE 113 SPAIN MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 91

TABLE 114 SPAIN MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 91

TABLE 115 SPAIN MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 91

TABLE 116 SPAIN MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 92

TABLE 117 SPAIN MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 92

TABLE 118 ITALY MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 93

TABLE 119 ITALY MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 93

TABLE 120 ITALY MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 93

TABLE 121 ITALY MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 94

TABLE 122 ITALY MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 94

TABLE 123 ITALY MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 94

TABLE 124 ITALY MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 95

TABLE 125 ITALY MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 95

TABLE 126 REST OF EUROPE MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 96

TABLE 127 REST OF EUROPE MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 96

TABLE 128 REST OF EUROPE MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 96

TABLE 129 REST OF EUROPE MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 97

TABLE 130 REST OF EUROPE MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 97

TABLE 131 REST OF EUROPE MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 97

TABLE 132 REST OF EUROPE MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 98

TABLE 133 REST OF EUROPE MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 98

TABLE 134 ASIA-PACFIC MEDICAL NUTRITION MARKET, BY COUNTRY 2020–2027 (USD MILLION) 99

TABLE 135 ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 100

TABLE 136 ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 100

TABLE 137 ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 101

TABLE 138 ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 101

TABLE 139 ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 101

TABLE 140 ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 102

TABLE 141 ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 102

TABLE 142 ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 102

TABLE 143 CHINA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 103

TABLE 144 CHINA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 103

TABLE 145 CHINA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 103

TABLE 146 CHINA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 104

TABLE 147 CHINA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 104

TABLE 148 CHINA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 104

TABLE 149 CHINA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 105

TABLE 150 CHINA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 105

TABLE 151 JAPAN MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 106

TABLE 152 JAPAN MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 106

TABLE 153 JAPAN MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 106

TABLE 154 JAPAN MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 107

TABLE 155 JAPAN MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 107

TABLE 156 JAPAN MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 107

TABLE 157 JAPAN MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 108

TABLE 158 JAPAN MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 108

TABLE 159 INDIA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 109

TABLE 160 INDIA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 109

TABLE 161 INDIA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 109

TABLE 162 INDIA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 110

TABLE 163 INDIA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 110

TABLE 164 INDIA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 110

TABLE 165 INDIA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 111

TABLE 166 INDIA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 111

TABLE 167 AUSTRALIA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 112

TABLE 168 AUSTRALIA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 112

TABLE 169 AUSTRALIA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 112

TABLE 170 AUSTRALIA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 113

TABLE 171 AUSTRALIA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 113

TABLE 172 AUSTRALIA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 113

TABLE 173 AUSTRALIA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 114

TABLE 174 AUSTRALIA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 114

TABLE 175 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 115

TABLE 176 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 115

TABLE 177 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 115

TABLE 178 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 116

TABLE 179 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 116

TABLE 180 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 116

TABLE 181 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 117

TABLE 182 REST OF ASIA-PACIFIC MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 117

TABLE 183 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY COUNTRY 2020–2027 (USD MILLION) 118

TABLE 184 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 119

TABLE 185 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 119

TABLE 186 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 119

TABLE 187 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 120

TABLE 188 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE

2020–2027 (USD MILLION) 120

TABLE 189 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 120

TABLE 190 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 121

TABLE 191 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 121

TABLE 192 MIDDLE EAST MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 122

TABLE 193 MIDDLE EAST MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 122

TABLE 194 MIDDLE EAST MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 122

TABLE 195 MIDDLE EAST MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 123

TABLE 196 MIDDLE EAST MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 123

TABLE 197 MIDDLE EAST MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 123

TABLE 198 MIDDLE EAST MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 124

TABLE 199 MIDDLE EAST MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 124

TABLE 200 AFRICA MEDICAL NUTRITION MARKET, BY TYPE 2020–2027 (USD MILLION) 125

TABLE 201 AFRICA MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 125

TABLE 202 AFRICA MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 125

TABLE 203 AFRICA MEDICAL NUTRITION MARKET, BY APPLICATION 2020–2027 (USD MILLION) 126

TABLE 204 AFRICA MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, BY TYPE 2020–2027 (USD MILLION) 126

TABLE 205 AFRICA MEDICAL NUTRITION MARKET FOR CANCER, BY TYPE 2020–2027 (USD MILLION) 126

TABLE 206 AFRICA MEDICAL NUTRITION MARKET FOR PULMONARY DISEASES, BY TYPE 2020–2027 (USD MILLION) 127

TABLE 207 AFRICA MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 127

TABLE 208 GLOBAL MEDICAL NUTRITION MARKET: KEY DEVELOPMENT 132

14 List of Figures

FIGURE 1 RESEARCH PROCESS OF MRFR 21

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 24

FIGURE 3 GLOBAL BIRTH RATE (PER THOUSAND), 2020 27

FIGURE 4 COUNTRY-WISE PERCENTAGE OF POPULATION AGED 65 YEARS & ABOVE, 2020 29

FIGURE 5 GLOBAL MEDICAL NUTRITION MARKET, BY SCREENING TYPE 2020 & 2027 (USD MILLION) 34

FIGURE 6 GLOBAL MEDICAL NUTRITION MARKET, BY PRODUCT TYPE 2020 & 2027 (USD MILLION) 40

FIGURE 7 GLOBAL MEDICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION 2020 & 2027 (USD MILLION) 46

FIGURE 8 GLOBAL MEDICAL NUTRITION MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 49

FIGURE 9 GLOBAL MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL 2020 & 2027 (USD MILLION) 56

FIGURE 10 GLOBAL MEDICAL NUTRITION MARKET, BY REGION 2020 & 2027 (USD MILLION) 60

FIGURE 11 AMERICAS MEDICAL NUTRITION MARKET, BY REGION COUNTRY 2020 (%) 61

FIGURE 12 NORTH AMERICA MEDICAL NUTRITION MARKET, BY COUNTRY 2020 (%) 65

FIGURE 13 EUROPE MEDICAL NUTRITION MARKET, BY COUNTRY 2020 (%) 78

FIGURE 14 ASIA PACFIC MEDICAL NUTRITION MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 100

FIGURE 15 MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 118

FIGURE 16 GLOBAL MEDICAL NUTRITION MARKET COMPETITIVE LANDSCAPE (%) 129

FIGURE 17 GLOBAL MEDICAL NUTRITION MARKET, MARKET SHARE ANALYSIS 2020 (%) 131

医療栄養市場

医療栄養市場アナリストは、2027年までに医療栄養は642.8億米ドル増加し、5.4%のCAGRで成長すると予測しています。

セグメンテーション

タイプ別 Pediatric Nutrition Elderly Nutrition Parenteral Nutrition Sports Nutrition
製品タイプ別 Amino Acid Solutions Multivitamin Supplements Antioxidants Lipid Emulsions Trace Elements Chamber Beads
By Route Of The Administration Oral Parenteral Intravenous
アプリケーション別 Pulmonary Diseases Cancer Gastrointestinal Diseases Obesity Diabetes Pediatric Malnutrition Renal Failure Neurological Diseases
流通チャネル別 Compounding Pharmacies Hospitals Retail Pharmacies E Commerce Websites

キープレーヤー

  • Solace Nutrition (U.K.)
  • AYMES Nutrition International Ltd. (U.K.)
  • Mead Johnson and Company LLC. (U.S.)
  • Nestle Health Science (Switzerland)
  • Braun Melsungen AG (Germany)
  • NeoMed (U.S.)
  • Abbott Nutrition (U.S.)
  • Baxter International (U.S.)
  • Danone (France)

運転手

  • increase in consumption of fast-food and changing lifestyles
Speak to Analyst Request a Free Sample

医療栄養市場の概要:


医療栄養市場アナリストは、2027年までに医療栄養は642.8億米ドル増加し、5.4%のCAGRで成長すると予測しています。


医療栄養市場は、栄養失調の問題が増大しているため、患者の栄養ニーズを満たすために必要です。特に、糖尿病、慢性閉塞性肺疾患(COPD)、がん、免疫系障害、胃腸障害などの慢性疾患では、医療栄養が非常に重要です。医療栄養市場の成長は、薬用食品や飲料に関する意識の高まりと、病気の発生率の上昇によって推進されています。


COVID19 分析


COVID19のパンデミックは、10万人以上に影響を及ぼしました。病気の蔓延を防ぐために、多くの人が家をロックしました。この病気に起因する医療栄養に対する意識の高まりに伴い、医療栄養市場は驚異的な成長を期待できます。


ロックダウンの結果、多くの企業が精神的および身体的障害の予防または治療に役立つ栄養製品を開発しました。これにより、私たちの国と各個人の両方が栄養価を維持することができます。健康を促進するための政府のイニシアチブも利用できます。人口はブラジル、ロシア、イタリアなどのさまざまな国でかなり減少しており、コロナの症例はインド、英国、米国などの他のいくつかの国では日々増加しています。医師は、対面して対処しなければならなかったため、男性に嫌われていました。しかし、このおかげで遠隔治療が増えました!


医療栄養市場のダイナミクス:


ドライバー


食事の変化や、労働時間の延長や喫煙などのライフスタイルの変化により、栄養素の吸収が低下しているため、医療栄養業界は急速な成長を遂げています。成長している産業は、高齢者の消化器系の低下による医療栄養です。インドや中国のような発展途上国では、人口の増加により医療栄養の需要が高まるでしょう。


拘束


さまざまな国によって施行されている政府の政策は、医療栄養市場の成長を制限しています。手頃な価格の要素だけでなく、製品の価格も非常に重要です。さらに、知識の欠如と厳格な政府ガイドラインにより、世界市場における医療栄養市場の成長が制限されています。


機会


将来的には、より多くの人々が栄養価と適切な栄養を摂取することの重要性を認識するようになるにつれて、医療栄養価のさらなる成長が見られるはずです。医療栄養市場の価値に対する意識の高まりも、市場の発展に貢献しています。胃の問題や糖尿病に関連する問題の増加により、医療栄養もますます多くの課題に直面するでしょう。


拘束


さまざまな政府によって実施されている貧弱な償還政策が、医療栄養市場の成長を妨げています。さらに、誰もがそれを買う余裕があるわけではないので、コスト要因も重要な役割を果たします。さらに、サプリメントの使用に関する知識の欠如と厳格な政府ガイドラインも、世界中の医療栄養市場の成長の障壁となっています。


医療栄養市場の技術分析


出生率の上昇により、世界中で早産の可能性が高まっています。脳性麻痺、感覚障害、呼吸器疾患、学習障害など、フルタイム出産と比較して、早産に関連する健康関連の合併症がたくさんあります。さらに、早産は早期死亡につながる可能性があります。これが、いくつかの政府が、できるだけ多くの命を救うために栄養産業を拡大するための真剣なイニシアチブを設定している理由です。慢性疾患の増加に伴い、年齢に関係なく医療栄養も必要です。適切な栄養は人の健康に不可欠です。


セグメントの概要


世界の医療栄養市場には、タイプ、製品タイプ、用途、流通チャネルの4種類があります。


タイプ別:


種類によって、食品は小児栄養、高齢者栄養、非経口栄養、スポーツ栄養に分類されます。インドや中国などの国々での早産の増加により、小児栄養の需要が高まっていますオン、30%の最高シェアを保持しています。


製品タイプ別:


アミノ酸溶液、マルチビタミンサプリメント、抗酸化物質、脂質エマルジョン、微量元素、チャンバービーズだけでなく、市場はさまざまな製品を提供しています。市場シェアの面では、アミノ酸溶液が最大のシェアを占めています。予測期間中、脂質エマルジョンの医療栄養市場は高い成長が見込まれます。


行政の経路:


経口

、非経口、静脈内投与など、多くの種類の投与方法があります。


アプリケーション別:


適用の結果、医療栄養市場は肺疾患、癌、胃腸疾患、肥満、糖尿病、小児栄養失調、腎不全、神経疾患に分けられました。


流通チャネル別:


調剤薬局、病院、小売薬局、eコマースWebサイトはすべて、流通チャネルに基づいて医療栄養市場を分割しています。


地域分析


医療栄養の医療栄養市場には、南北アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカの4つの主要な地域セグメントが含まれます。アメリカの消費は医療栄養市場を牽引しています。米国の消費は北米の消費を支配しています。この地域では、老年医学などの障害や病気の蔓延により、医療栄養の市場が成長しています。


国際的な医療栄養業界のシェアでは、ヨーロッパ地域が2番目に大きなシェアを占めています。CAGRに関しては、アジア太平洋地域は予測期間中に最も速いペースで成長し、4.5%の割合で成長すると予想されます。


競争環境


世界レベルでは、医療栄養の市場を構成する主要企業には、プリムス・ファーマシューティカルズ(米国)、ニュートリシア・アドバンスト・メディカル・ニュートリション(オランダ)、ソレス・ニュートリション(英国)、エイムス・ニュートリション・インターナショナル(英国)、ミード・ジョンソン・アンド・カンパニーLLCが含まれます。(米国)、ネスレヘルスサイエンス(スイス)、ブラウンメルスンゲンAG(ドイツ)、NeoMed(米国)、アボットニュートリション(米国)、バクスターインターナショナル(米国)、ダノン(フランス)。


世界的な医療栄養業界の巨人は、イノベーション、買収、製品開発、拡大など、さまざまな戦略を使用して成功を収めています。


最近の動向




  • バクスターズは、非経口栄養で高タンパク質レベルを提供するために、2020年9月にClinimix EとClinimixの導入を発表しました。




  • 栄養失調または栄養失調のリスクがある人々に食事管理を提供することは非常に重要であり、AYMES Internationalは、2020年4月から利用可能になる「AYMES ActaSolve Smoothie」と呼ばれる経口栄養補助食品を開発しました。




  • 栄養士と栄養士は、通常、食生活が調和していることを確認するために、ほとんどの国から認可を受けています。さらに、有機医療栄養市場は、誰もが有機製品を開発することによってビーガン人口に応えようとしているため、医療栄養業界での売り上げが増加しています。




  • いくつかの国際的な医学会、医療機関、および医師や医療従事者のための厳格な栄養基準を確立している他の団体があります。アメリカでは、栄養栄養学アカデミーが栄養基準の定義において重要な役割を果たしています。




  • 2018-2019年の時点で、ネスレヘルスサイエンスはスターバックスコーポレーションの消費者向けパッケージ商品およびフードサービス製品の販売権を取得しました。ネスレは、個人栄養の製品ラインを拡大するだけでなく、ポートフォリオも拡大しました。




レポート概要


この市場レポートには、医療栄養市場に関連するすべての情報、それを推進する要因、および過去の医療栄養市場に先んじた機会が含まれています。このレポートでは、推定成長率に言及することに加えて、パンデミック時に医療栄養業界が直面した課題も構成しています。レポートはまた、開発された新技術と行われた研究開発、および企業によって実行される研究開発と増加する研究開発に光を当てる状況の技術的見解を提供します。このレポートは、今後数年間のこの市場の成長と発展を知るのに役立ちます。


テクノロジー

Report Scope:
Report Attribute/Metric Details
  Market Size   USD 64.28 Billion
  CAGR   5.40%
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Product Type, Route of Administration, Application, Distribution Channel
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   NeoMed (U.S.), Primus Pharmaceuticals (U.S.), AYMES Nutrition International Ltd. (U.K.), Abbott Nutrition (U.S.), Nutricia Advanced Medical Nutrition (Netherlands), Danone (France), Baxter International (U.S.), Mead Johnson and Company, LLC. (U.S.), Braun Melsungen AG (Germany), Solace Nutrition (U.K.), Nestle Health Science (Switzerland)
  Key Market Opportunities   Increasing awareness about infant nutrition value also acts as a contributing factor
  Key Market Drivers   The increase in consumption of fast-food and changing lifestyles


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Medical nutrition market projected to grow at approximately 5.4% CAGR during the assessment period (2020-2027).

The valuation of the medical nutrition market is estimated to increase to USD 64.28 BN by the end of 2027.

Rising prevalence of chronic diseases and awareness about the benefits among general population, are major tailwinds pushing the growth of the global medical nutrition market.

North America holds the largest share in the global medical nutrition market, followed by Europe and the Asia Pacific, respectively.

NeoMed (US), Primus Pharmaceuticals (US), Inc., AYMES Nutrition International Ltd. (UK), Abbott Nutrition (US), Nutricia Advanced Medical Nutrition (Netherland), Danone (France), Baxter International (US), Mead Johnson & Company, LLC. (US), B. Braun Melsungen AG (Germany), Solace Nutrition (UK), and Nestlé Health Science (Switzerland), are some of the top players operating in the global medical nutrition market.

Medical Nutrition Market: Competitive Landscape


Abbott Nutrition, Mead Johnson Nutrition Co., Nestle, Danone Nutricia, NeoMed, B. Braun Melsungen AG, Nutricia, and Baxter International, Inc. collectively accounted for more than 47% of the market share of the global medical nutrition market in 2017. These companies continue to retain their strong global presence through expansion, merger & acquisition, and extensive product portfolio.


The medical nutrition market is currently dominated by Abbott Nutrition with 19.6% of the total market share. Abbott Nutrition operates as a subsidiary of Abbott Laboratories. The company focuses on discovery, development, manufacturing, and sales of healthcare products. The company operates through four reportable segments, namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Furthermore, the company has two non-reportable segments, namely, diabetes care and medical optics. The diabetes care division of the company is located in California, US and provides blood glucose meters, blood glucose test strips, sensors, data management decision software, and accessories. The company manufacturers its blood glucose test strips at Witney, the UK site. For example, in March 2016, Abbott introduces two new products Ensure & Enlive into the market to help rebuild lost muscle and regain strength and energy by pairing the latest in science and nutrition. This will help the company to extend its product portfolio in muscle and strength category of products.


Mead Johnson Nutrition Company is the second position in term of market share for the global medical nutrition market. The company operates as a subsidiary of Johnson & Johnson Services Inc. J&J manufactures medical devices for various specialties, such as orthopedics, cardiovascular diseases, and many others. J&J Services has acquired and merged with various other companies to expand its portfolio of endoscopic devices. Ethicon, a subsidiary of J&J offers a broad range of suture needle products. Janssen Pharmaceuticals, Inc. is one of the companies of Johnson and Johnson engaged in developing medicines for the treatment of pain.


For Example, In December 2017, Nestlé confirmed on the acquisition of privately held Atrium Innovations, one of the global leader focusing on nutritional health products. This strategic acquisition made by Nestlé will enhance the company’s growth opportunities in consumer healthcare to complement the company’s focus on high-growth food and beverage categories. This transaction will get closed in the first quarter of 2018 followed by completing customary approvals and closing conditions.


Danone Nutricia operates as a food company worldwide. The company distributes its products through retail chains and traditional market outlets, as well as through hospitals, clinics, and pharmacies


Furthermore, in October 2014, Nature’s Products acquired Nutri-Health and Sedona Labs leading brands in the probiotic and enzyme nutritional supplement market. With the acquisition of these two brands, the company has reserved a reasonable amount of share in global medical nutrition market. 


These strategies implied by the players in this market is continuous innovation and development of the new and better products to beat the opponents and strive in this big market.